Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
This study is currently recruiting participants.
Study NCT00136760 Information provided by National Institute on Drug Abuse (NIDA)
First Received: August 25, 2005 Last Updated: August 25, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tobacco Use Disorder
Additional conditions recognized in this trial
Disease
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Pathologic Processes
Substance-Related Disorders
Interventions listed in this trial
Bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
Brown University
Back to top of Main Content
